Not logged inReal-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study
Wheatley-Price, Paul; Navani, Vishal; Pabani, Aliyah; Routy, Bertrand; Snow, Stephanie; Denault, Marie-Helene; Kim, YongJin; Syed, Iqra; Devost, Natalie; Hui, Daphne; Qadeer, Rana A.; Arora, Paul; Velummailum, Russanthy; Springford, Aaron; McKibbon, Chelsea; Ho, Cheryl
Share
Save
Share
Save